Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
October 22, 2020
Homology Medicines Unveils New In Vivo Gene Therapy Development Program for Hunter Syndrome
October 21, 2020
Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs at IDWeek 2020
October 21, 2020
Vor Biopharma Appoints Matthew R. Patterson to its Board of Directors
October 8, 2020
Impel Neuropharma Presents Data From Pivotal Phase 3 Registration Study of INP104 for the Treatment of Acute Migraine at 2020 Migraine Trust Virtual Symposium
October 5, 2020
Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President
October 5, 2020
Magnetic Insight Awarded NIH SBIR grant to Advance In Vivo Biosensing Through Color Magnetic Particle Imaging
October 1, 2020
Akouos Announces Key Leadership Appointments
September 29, 2020
Vor Biopharma and Arbor Biotechnologies to Collaborate on Engineered Hematopoietic Stem-Cell Therapies
September 25, 2020
IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations
September 23, 2020
Pear Therapeutics Announces Availability of reSET® and reSET-O® to Wellpath Community Care Center Patients; Wellpath to Bring Prescription Digital Therapeutics For Addiction to New Outpatient Treatment Centers
« Previous Page
1
…
34
35
36
37
38
…
103